Amanote Research
Register
Sign In
Translating the Molecular Hallmarks of Colorectal Cancer to Patient Therapies: An Interview With Owen Sansom
DMM Disease Models and Mechanisms
- United Kingdom
doi 10.1242/dmm.017350
Full Text
Open PDF
Abstract
Available in
full text
Categories
Immunology
Molecular Biology
Biochemistry
Microbiology
Neuroscience
Medicine
Genetics
Date
July 22, 2014
Authors
Unknown
Publisher
The Company of Biologists
Related search
The Molecular Hallmarks of the Serrated Pathway in Colorectal Cancer
Cancers
Cancer Research
Oncology
Molecular Chess? Hallmarks of Anti-Cancer Drug Resistance
BMC Cancer
Cancer Research
Oncology
Genetics
Translating Science in More Ways Than One: An Interview With Frances Balkwill
DMM Disease Models and Mechanisms
Immunology
Molecular Biology
Biochemistry
Microbiology
Neuroscience
Medicine
Genetics
Molecular Pathogenesis of Colorectal Cancer
Klinicka Onkologie
Oncology
Targeting Cancer: An Interview With Tyler Jacks
DMM Disease Models and Mechanisms
Immunology
Molecular Biology
Biochemistry
Microbiology
Neuroscience
Medicine
Genetics
Ovarian Cancer: Emerging Molecular-Targeted Therapies
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
Survivor and Patient Advocate: An Interview With T.J. Sharpe
Melanoma Management
Dermatology
Oncology
Molecular Characterization of ERBB2 -Amplified Colorectal Cancer Identifies Potential Mechanisms of Resistance to Targeted Therapies: A Report of Two Instructive Cases
Cold Spring Harbor molecular case studies
Biochemistry
Molecular Medicine
Genetics
Molecular Targeted Therapies for Pancreatic Cancer
American Journal of Surgery
Medicine
Surgery
